Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States

Archives of Surgery

Volumn 142, Issue 7, 2007, Pages 624-631

  Ricciardi, Rocco ^a,c   Rothenberger, David A ^a   Madoff, Robert D ^a   Baxter, Nancy N ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE; COHORT ANALYSIS; COLITIS; COLON RESECTION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; REGRESSION ANALYSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CLOSTRIDIUM DIFFICILE; COHORT STUDIES; COLECTOMY; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIDEMIOLOGIC STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; POPULATION SURVEILLANCE; PREVALENCE; SURVIVAL RATE; UNITED STATES;

EID: 34447542645     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.7.624     Document Type: Article

References (33)

1. Weir E, Flegel K. Protecting against Clostridium difficile illness. CMAJ. 2005;172(9):1178.
2. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004; 47(10):1620-1626.
3. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204-210.
4. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg. 2002;137(10):1096-1100.
5. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235(3):363-372.
6. Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466-472.
7. Eggertson L. C difficile may have killed 2,000 in Quebec: study. CMAJ. 2005;173 (9):1020-1021.
8. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366(9491):1079-1084.
9. Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol KA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg. 2004;199:31-38.
10. Rathore SS, Epstein AJ, Volpp KG, Krumholz HM. Hospital coronary artery bypass graft surgery volume and patient mortality. Ann Surg. 2004;239(1):110-117.
11. Shen JJ, Washington EL, Aponte-Soto L. Racial disparities in the pathogenesis and outcomes for patients with ischemic stroke. Manag Care Interface. 2004; 17(3):28-34.
12. Lipsett PA, Samantaray DK, Tam ML, Bartlett JG, Lillemoe KD. Pseudomembranous colitis: a surgical disease? Surgery. 1994;116(3):491-496.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
14. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr. Assessing illness severity: does clinical judgment work? J Chronic Dis. 1986; 39(6):439-452.
15. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169(1):127-133.
16. Frost F, Hurley JS, Petersen HV, Casciano RN. Estimated incidence of Clostridium difficile infection. Emerg Infect Dis. 1999;5(2):303-304.
17. Karlström O, Fryklund B, Tullus K, Burman LG; Swedish C difficile Study Group. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis. 1998;26(1):141-145.
18. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis. 2004;189(9):1585-1589.
19. Layton BA, McDonald LC, Gerding DN, Liedtke LA, Strausbaugh LJ. Changing patterns of Clostridium difficile disease: a report from infectious diseases physicians. In: Program and abstracts of the Infectious Diseases Society of America 2004 Annual Meeting; September 30-October 4, 2004; Boston, MA. Abstract 563.
20. Louie TJ. How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile? CMAJ. 2005;173(9):1049-1050.
21. Pépin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254-1260.
22. Health Protection Agency. CDR weekly. http://www.hpa.org.uk/cdr/archives /archive05/News/news2405.htm. Published June 16, 2005. Accessed November 8, 2005.
23. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-2449.
24. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441.
25. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005;40(11): 1586-1590.
26. Fernandez A, Anand G, Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol. 2004; 38(5):414-418.
27. Bendle JS, James PA, Bennett PM, Avison MB, Macgowan AP, Al-Shafi KM. Resistance determinants in strains of Clostridium difficile from two geographically distinct populations. Int J Antimicrob Agents. 2004;24(6):619-621.
28. Robinson MC, Monson TP, Menon A, et al. The correlation of fluoroquinolone usage to an increasing rate of Clostridium difficile-associated disease in two hospitals. In: Program and abstracts of the Infectious Diseases Society of America 2005 Annual Meeting; October 6-9, 2005; San Francisco, CA. Abstract 1126.
29. Salgado CD, Mauldin PD, Steed LL, Bosso JA. Preliminary analysis of the association between fluoroquinolone (FQ) use and Clostridium difficile (C diff ) rates. In: Program and abstracts of the Infectious Diseases Society of America 2005 Annual Meeting; October 6-9, 2005; San Francisco, CA. Abstract 1127.
30. Nair S, Yadav D, Corpuz M, Pitchumoni CS. Clostridium difficile colitis: factors influencing treatment failure and relapse: a prospective evaluation. Am J Gastroenterol. 1998;93(10):1873-1876.
31. Young GP, Bayley N, Ward P, St John DJ, McDonald MI. Antibiotic- associated colitis caused by Clostridium difficile: relapse and risk factors. Med J Aust. 1986;144(6):303-306.
32. Schweitzer MA, Sweiss I, Silver DL, Stellato TA. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients. Am Surg. 1996;62 (7):603-607.
33. Schoenman JA, Sutton JP, Kintala S, Love D, Maw R. The value of hospital discharge databases. http://www.hcup-us.ahrq.gov/reports/final_report.pdf. Accessed June 15, 2005.